LivingGLP1
Study S001052

GLIDE-HF Registry: A Prospective, Single-Center, Observational Cohort of Patients With Obesity-Related Heart Failure With Preserved Ejection Fraction, With GLP-1/GIP Receptor Agonist Therapy as an Observed Exposure and Serial Exercise Echocardiographic Phenotyping

Registration

Registration
NCT07787936
Acronym
GLIDE-HF
Study type
OBSERVATIONAL
Status
NOT_YET_RECRUITING
Enrollment
150
Start
2027-01-01
Primary completion
2031-01-01
Lead sponsor
Miedziowe Centrum Zdrowia SA
Conditions
Heart Failure With Preserved Ejection Fraction; Obesity; Diastolic Heart Failure; Pulmonary Hypertension; Iron Deficiency
Interventions
DRUG:GLP-1 / GIP receptor agonist
Results posted
FALSE
Individual participant data sharing
NO
Secondary identifiers
OTHER:Ethics

Registered primary outcomes

  • Trajectory of exercise E/e' over time in GLP-1/GIP-exposed patients [Baseline, 12, 24, and 52 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.